In addition, animals lacking ASIC channels (ASIC1-/-) show no obvious defects in physiological function [102], potentially providing hope for novel clinical therapies for both ischaemic stroke and the need to modify schizophrenia treatment regimens tailored to specific symptoms and patient subgroups. This evidence concerns the gene ASIC1 and ischemic stroke.